Navigation Links
Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction
Date:5/2/2011

MISSISSAUGA, Ontario, May 2, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today congratulated Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Cephalon, Inc. (NASADQ: CEPH) on their announcement that Cephalon has agreed to be acquired by Teva.  In response to the news, Valeant has withdrawn its consent solicitation.

"We believe that this announcement is positive news for Cephalon stockholders and we are pleased that Teva has paid what we believe is a very full value for the company and as a result, have withdrawn our consent solicitation," stated J. Michael Pearson, chairman and chief executive officer.  "As Cephalon stockholders ourselves with over a million shares owned, we will benefit from this transaction without participating further in the process.  We will remain disciplined on our M&A strategy and will look to deploy our freed-up capital on other opportunities to create value for our shareholders."

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant can be found at www.valeant.com.

Forward-looking Statements

This press release may contain forward-looking statements, including, but not limited to, statements regarding Valeant's expectation to benefit from the proposed acquisition of Cephalon by Teva and opportunities to create value for Valeant shareholders. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Valeant Pharmaceuticals to Announce 2011 First Quarter Results on May 9, 2011
2. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
3. Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013
4. Regulatory Update - GSK and Valeant Respond to FDA on ezogabine
5. Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors
6. Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
7. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
8. Promius Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States
9. Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
10. GSK and Valeant Receive European Authorisation for Trobalt (retigabine)
11. Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... 31, 2015 Noser Health ... to deliver new platform ... citizen-owned health data transaction platform, announced today strategic partnerships ... to engineer and bring to market its global health ... "Our business model is built on trust, ...
(Date:8/30/2015)... August 30, 2015 La ... l cuidado al paciente ...   Royal Philips  (NYSE: PHG, ... IntelliSpace Cardiovascular , un sistema web de gestión ... acceder, analizar y compartir imágenes cardiovasculares e información en ...
(Date:8/29/2015)... y LONDRES, August 29, 2015 ... para los sistemas de imagen por Ultrasonidos ... Ecografía, tiempos de examen rápidos y un flujo de ... confianza diagnóstica en el proceso de detección de Cardiopatías ... PHIA) ha anunciado hoy el lanzamiento europeo de ...
Breaking Medicine Technology:healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 2healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 3healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 4Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5
... Inc. (NYSE: PFE ) today announced ... Innovation, an entrepreneurial network of partnerships with leading ... by accessing leading translational researchers.  The University of ... the network. (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) ...
... 16, 2010 Baxa Corporation , a leading ... operations, today announced significant upgrades to its DoseEdge ... workflow management tool that verifies the use of correct ... chemo, TPN and oral liquid doses.  This release includes ...
Cached Medicine Technology:Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco 2Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco 3Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco 4Baxa Releases Upgrade for DoseEdge™ - the Only Dose Management System With Comprehensive Formulary Management Functionality 2Baxa Releases Upgrade for DoseEdge™ - the Only Dose Management System With Comprehensive Formulary Management Functionality 3Baxa Releases Upgrade for DoseEdge™ - the Only Dose Management System With Comprehensive Formulary Management Functionality 4
(Date:8/30/2015)... ... August 31, 2015 , ... The acknowledgement from Caribbean Journal comes after Grace ... 2015. The island of Providenciales itself received a TripAdvisor Traveller's Choice Award in ... Bay is offering a special promotion for newlyweds and honeymooners to celebrate this amazing ...
(Date:8/30/2015)... ... August 31, 2015 , ... Although middle ... tax receipts, issues that are critically important to them are often overlooked when ... lobbyists monitoring proposed legislation and changing tax and regulatory policies. Smaller companies, which ...
(Date:8/30/2015)... , ... August 31, 2015 , ... Negotiating an FDA ... 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/importholdcrisis , US authorities are holding ... products, and imports from India. , With alerts on an uptick and a new ...
(Date:8/30/2015)... ... August 31, 2015 , ... Intellitec ... Annual Convention & Expo October 5th & 6th in San Antonio, TX. Dedicated ... convention brings industry professionals from all over the country come to share the ...
(Date:8/30/2015)... ... 31, 2015 , ... ChopChop Kids, the nonprofit publisher of ... elected two new officers to serve on the organization’s Board of Directors in ... teaching kids to cook real food with their families and help continue to ...
Breaking Medicine News(10 mins):Health News:Grace Bay Beach Named a Top Beach Destination for Weddings 2Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 2Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 3Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 4Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 2Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 3Health News:Intellitec Solutions to feature Microsoft Dynamics GP at AHCA/NCAL 66th Annual Convention & Expo 2Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 2Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 3
... will soon have the opportunity to take part in ... the autoimmune disease, ankylosing spondylitis. Approximately 200 patients will ... aims to merge the latest molecular discoveries published by ... medical expertise of physicians and researchers at West China ...
... glaucoma and other conditions , , ... times a day can be difficult for patients to do, and because ... the dose is actually absorbed by the eye. Now, researchers led by ... Delivery at Children,s Hospital Boston, have developed special contact lenses that can ...
... , , , ... Allscripts (Nasdaq: MDRX ), the leader in software, ... Medfusion, the leader in patient-to-provider online communication solutions, today announced ... for Allscripts Electronic Health Record (EHR) and Practice Management clients ...
... 21 /PRNewswire-USNewswire / -- Representatives from leading national ... to honor the 2009 winners of the National Family ... and MetLife Foundation. The event recognized community-based programs supporting ... responsiveness to caregiver needs. , ...
... they,d prefer more flex time and balance in life, , TUESDAY, ... all again, most female surgeons would choose the same career path, ... in the July issue of Archives of Surgery , revealed ... because of their rigorous training and work schedule. , Few female ...
... combined with air pollution, smoking, it raises chances of condition, ... pollution from cars can increase a child,s chances of developing ... get even higher, a new study finds. , For children ... risk, parental stress also increases the risk for asthma, the ...
Cached Medicine News:Health News:Study aims to induce recovery from ankylosing spondylitis 2Health News:A Drug-Dispensing Contact Lens 2Health News:A Drug-Dispensing Contact Lens 3Health News:Allscripts and Medfusion Partner to Provide Patient Portal to Physician Practices Nationwide 2Health News:Allscripts and Medfusion Partner to Provide Patient Portal to Physician Practices Nationwide 3Health News:Allscripts and Medfusion Partner to Provide Patient Portal to Physician Practices Nationwide 4Health News:The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 2Health News:The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 3Health News:The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 4Health News:The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 5Health News:Female Surgeons Like What They Do, Survey Finds 2Health News:Parental Stress Boosts Kids' Asthma Risk 2Health News:Parental Stress Boosts Kids' Asthma Risk 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: